title: A case of rituximab-induced hepatitis.
abstract: A case of hepatitis in a patient receiving rituximab for ITP is reported. After an extensive workup, no infectious or autoimmune etiology could be found. The authors believe that this represents a case of drug-induced hepatitis, which has not been reported for this agent in the past.
authors.affiliation: Carl and Dorothy Bennett Cancer Center, Stamford, Connecticut 06902, USA. cjd46@cornell.edu
authors.forename: Christopher Joseph
authors.initials: CJ
authors.lastname: Del Prete
authors.forename: Neil S
authors.initials: NS
authors.lastname: Cohen
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000175:diagnosis*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab